Hélène Moins-Teisserenc

16PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 13, 2025
Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.

Adèle de Masson, Marie Beylot-Barry, Caroline Ram-Wolff

|Feb 14, 2022
Flow cytometry for the assessment of blood tumour burden in cutaneous T-cell lymphoma: towards a standardized approach.

Maarten H Vermeer, Helene Moins-Teisserenc, Martine Bagot

|Jan 18, 2022
Mogamulizumab induces long-term immune restoration and reshapes tumour heterogeneity in Sézary syndrome.

Marie Roelens, Adèle de Masson, Anais Andrillon

|Dec 14, 2021
Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients.

Adèle de Masson, Delphine Darbord, Gabor Dobos

|Nov 02, 2021
Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma.

Nicolas Leupin, Pier Luigi Zinzani, Franck Morschhauser

|Apr 03, 2021
Specific Patterns of Blood ILCs in Metastatic Melanoma Patients and Their Modulations in Response to Immunotherapy.

Louise Rethacker, Marie Roelens, Claudia Bejar

Pageof 3

Frequent Collaborators

10 joint publications

Adèle de Masson

8 joint publications

Martine Bagot

3 joint publications

Jean-David Bouaziz

3 joint publications

Maxime Battistella